| Product Code: ETC9940006 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Candidiasis Therapeutics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Candidiasis Therapeutics Market - Industry Life Cycle |
3.4 United Kingdom (UK) Candidiasis Therapeutics Market - Porter's Five Forces |
3.5 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume Share, By Symptom Type, 2021 & 2031F |
3.7 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.9 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Candidiasis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of candidiasis infections in the United Kingdom |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of candidiasis |
4.2.3 Technological advancements in the development of candidiasis therapeutics |
4.3 Market Restraints |
4.3.1 Limited availability of effective treatment options for certain types of candidiasis infections |
4.3.2 High cost associated with candidiasis therapeutics |
4.3.3 Stringent regulatory requirements for the approval of new candidiasis treatment drugs |
5 United Kingdom (UK) Candidiasis Therapeutics Market Trends |
6 United Kingdom (UK) Candidiasis Therapeutics Market, By Types |
6.1 United Kingdom (UK) Candidiasis Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Oropharyngeal Candidiasis, 2021- 2031F |
6.1.4 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Genital Candidiasis, 2021- 2031F |
6.1.5 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Invasive Candidasis, 2021- 2031F |
6.2 United Kingdom (UK) Candidiasis Therapeutics Market, By Symptom Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Oral Thrush, 2021- 2031F |
6.2.3 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Fatigue, 2021- 2031F |
6.2.4 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Urinary Tract Infection (UTI), 2021- 2031F |
6.3 United Kingdom (UK) Candidiasis Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4 United Kingdom (UK) Candidiasis Therapeutics Market, By Mode of Administration |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.3 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.5 United Kingdom (UK) Candidiasis Therapeutics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 United Kingdom (UK) Candidiasis Therapeutics Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 United Kingdom (UK) Candidiasis Therapeutics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 United Kingdom (UK) Candidiasis Therapeutics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Candidiasis Therapeutics Market Export to Major Countries |
7.2 United Kingdom (UK) Candidiasis Therapeutics Market Imports from Major Countries |
8 United Kingdom (UK) Candidiasis Therapeutics Market Key Performance Indicators |
8.1 Number of candidiasis cases diagnosed annually in the United Kingdom |
8.2 Adoption rate of newly developed candidiasis therapeutics in the market |
8.3 Patient satisfaction and adherence rates with candidiasis treatment regimens |
9 United Kingdom (UK) Candidiasis Therapeutics Market - Opportunity Assessment |
9.1 United Kingdom (UK) Candidiasis Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Candidiasis Therapeutics Market Opportunity Assessment, By Symptom Type, 2021 & 2031F |
9.3 United Kingdom (UK) Candidiasis Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 United Kingdom (UK) Candidiasis Therapeutics Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.5 United Kingdom (UK) Candidiasis Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 United Kingdom (UK) Candidiasis Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Candidiasis Therapeutics Market - Competitive Landscape |
10.1 United Kingdom (UK) Candidiasis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Candidiasis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here